Prognostic significance of clonal diversity of immunoglobulin gene rearrangements in patients with diffuse large B-cell lymphoma

Muh Hwa Yang, Chueh Chuan Yen, Shu Chung Chiang, Li Yuan Bai, Kuan Der Lee, Liang Tsai Hsiao, Ta Chung Chao, Wei Shu Wang, Jin Hwang Liu, Tzeon Jye Chiou, Po Min Chen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Clonal diversity of the immunoglobulin (Ig) gene rearrangement represents the oligoclonality of B-cell neoplasm, and has been shown to be a marker for poor prognosis in acute lymphoblastic leukemia. However, no previous report has addressed its prognostic impact in diffuse large B-cell lymphoma (DLBCL). We investigated the clinical significance of clonal diversity in DLBCL patients. Lymph node samples from 98 DLBCL patients were examined for Ig heavy and light chain gene rearrangements using Southern blot analysis. Clonal diversity was defined as oligoclonality detected on Southern blotting as previously described, and PCR analysis for IgH oligoclonality was performed on parts of DLBCL samples with clonal diversity for confirming the Southern blot analysis results. We found that clonal diversity could be detected in 36 (36.7%) of DLBCL patients, and PCR analysis showed concordant results. Regarding the clinical relevance, clonal diversity was significantly associated with relapse or refractory disease. Survival analysis showed that clonal diversity is an independent prognostic factor in DLBCL (p=0.05, Cox's proportional hazard method), and stratified analyses found the most significant subgroup is the high-intermediate risk category (p=0.01, log-rank test). We conclude that clonal diversity of Ig gene rearrangements is associated with a high risk of relapse or refractory disease in DLBCL patients. It is also a factor of poor prognosis in DLBCL, especially for high-intermediate risk category.

Original languageEnglish
Pages (from-to)503-508
Number of pages6
JournalOncology Reports
Volume13
Issue number3
Publication statusPublished - Mar 2005
Externally publishedYes

Fingerprint

Immunoglobulin Genes
Lymphoma, Large B-Cell, Diffuse
Gene Rearrangement
Southern Blotting
Immunoglobulin Light Chain Genes
Immunoglobulin Heavy Chain Genes
Recurrence
Polymerase Chain Reaction
Survival Analysis
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Lymphocytes
Lymph Nodes

Keywords

  • Clonal diversity
  • Diffuse large B-cell lymphoma
  • Immunoglobulin gene rearrangement

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Yang, M. H., Yen, C. C., Chiang, S. C., Bai, L. Y., Lee, K. D., Hsiao, L. T., ... Chen, P. M. (2005). Prognostic significance of clonal diversity of immunoglobulin gene rearrangements in patients with diffuse large B-cell lymphoma. Oncology Reports, 13(3), 503-508.

Prognostic significance of clonal diversity of immunoglobulin gene rearrangements in patients with diffuse large B-cell lymphoma. / Yang, Muh Hwa; Yen, Chueh Chuan; Chiang, Shu Chung; Bai, Li Yuan; Lee, Kuan Der; Hsiao, Liang Tsai; Chao, Ta Chung; Wang, Wei Shu; Liu, Jin Hwang; Chiou, Tzeon Jye; Chen, Po Min.

In: Oncology Reports, Vol. 13, No. 3, 03.2005, p. 503-508.

Research output: Contribution to journalArticle

Yang, MH, Yen, CC, Chiang, SC, Bai, LY, Lee, KD, Hsiao, LT, Chao, TC, Wang, WS, Liu, JH, Chiou, TJ & Chen, PM 2005, 'Prognostic significance of clonal diversity of immunoglobulin gene rearrangements in patients with diffuse large B-cell lymphoma', Oncology Reports, vol. 13, no. 3, pp. 503-508.
Yang, Muh Hwa ; Yen, Chueh Chuan ; Chiang, Shu Chung ; Bai, Li Yuan ; Lee, Kuan Der ; Hsiao, Liang Tsai ; Chao, Ta Chung ; Wang, Wei Shu ; Liu, Jin Hwang ; Chiou, Tzeon Jye ; Chen, Po Min. / Prognostic significance of clonal diversity of immunoglobulin gene rearrangements in patients with diffuse large B-cell lymphoma. In: Oncology Reports. 2005 ; Vol. 13, No. 3. pp. 503-508.
@article{34b5a4886dd84e7eba43ca0c683be30c,
title = "Prognostic significance of clonal diversity of immunoglobulin gene rearrangements in patients with diffuse large B-cell lymphoma",
abstract = "Clonal diversity of the immunoglobulin (Ig) gene rearrangement represents the oligoclonality of B-cell neoplasm, and has been shown to be a marker for poor prognosis in acute lymphoblastic leukemia. However, no previous report has addressed its prognostic impact in diffuse large B-cell lymphoma (DLBCL). We investigated the clinical significance of clonal diversity in DLBCL patients. Lymph node samples from 98 DLBCL patients were examined for Ig heavy and light chain gene rearrangements using Southern blot analysis. Clonal diversity was defined as oligoclonality detected on Southern blotting as previously described, and PCR analysis for IgH oligoclonality was performed on parts of DLBCL samples with clonal diversity for confirming the Southern blot analysis results. We found that clonal diversity could be detected in 36 (36.7{\%}) of DLBCL patients, and PCR analysis showed concordant results. Regarding the clinical relevance, clonal diversity was significantly associated with relapse or refractory disease. Survival analysis showed that clonal diversity is an independent prognostic factor in DLBCL (p=0.05, Cox's proportional hazard method), and stratified analyses found the most significant subgroup is the high-intermediate risk category (p=0.01, log-rank test). We conclude that clonal diversity of Ig gene rearrangements is associated with a high risk of relapse or refractory disease in DLBCL patients. It is also a factor of poor prognosis in DLBCL, especially for high-intermediate risk category.",
keywords = "Clonal diversity, Diffuse large B-cell lymphoma, Immunoglobulin gene rearrangement",
author = "Yang, {Muh Hwa} and Yen, {Chueh Chuan} and Chiang, {Shu Chung} and Bai, {Li Yuan} and Lee, {Kuan Der} and Hsiao, {Liang Tsai} and Chao, {Ta Chung} and Wang, {Wei Shu} and Liu, {Jin Hwang} and Chiou, {Tzeon Jye} and Chen, {Po Min}",
year = "2005",
month = "3",
language = "English",
volume = "13",
pages = "503--508",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Prognostic significance of clonal diversity of immunoglobulin gene rearrangements in patients with diffuse large B-cell lymphoma

AU - Yang, Muh Hwa

AU - Yen, Chueh Chuan

AU - Chiang, Shu Chung

AU - Bai, Li Yuan

AU - Lee, Kuan Der

AU - Hsiao, Liang Tsai

AU - Chao, Ta Chung

AU - Wang, Wei Shu

AU - Liu, Jin Hwang

AU - Chiou, Tzeon Jye

AU - Chen, Po Min

PY - 2005/3

Y1 - 2005/3

N2 - Clonal diversity of the immunoglobulin (Ig) gene rearrangement represents the oligoclonality of B-cell neoplasm, and has been shown to be a marker for poor prognosis in acute lymphoblastic leukemia. However, no previous report has addressed its prognostic impact in diffuse large B-cell lymphoma (DLBCL). We investigated the clinical significance of clonal diversity in DLBCL patients. Lymph node samples from 98 DLBCL patients were examined for Ig heavy and light chain gene rearrangements using Southern blot analysis. Clonal diversity was defined as oligoclonality detected on Southern blotting as previously described, and PCR analysis for IgH oligoclonality was performed on parts of DLBCL samples with clonal diversity for confirming the Southern blot analysis results. We found that clonal diversity could be detected in 36 (36.7%) of DLBCL patients, and PCR analysis showed concordant results. Regarding the clinical relevance, clonal diversity was significantly associated with relapse or refractory disease. Survival analysis showed that clonal diversity is an independent prognostic factor in DLBCL (p=0.05, Cox's proportional hazard method), and stratified analyses found the most significant subgroup is the high-intermediate risk category (p=0.01, log-rank test). We conclude that clonal diversity of Ig gene rearrangements is associated with a high risk of relapse or refractory disease in DLBCL patients. It is also a factor of poor prognosis in DLBCL, especially for high-intermediate risk category.

AB - Clonal diversity of the immunoglobulin (Ig) gene rearrangement represents the oligoclonality of B-cell neoplasm, and has been shown to be a marker for poor prognosis in acute lymphoblastic leukemia. However, no previous report has addressed its prognostic impact in diffuse large B-cell lymphoma (DLBCL). We investigated the clinical significance of clonal diversity in DLBCL patients. Lymph node samples from 98 DLBCL patients were examined for Ig heavy and light chain gene rearrangements using Southern blot analysis. Clonal diversity was defined as oligoclonality detected on Southern blotting as previously described, and PCR analysis for IgH oligoclonality was performed on parts of DLBCL samples with clonal diversity for confirming the Southern blot analysis results. We found that clonal diversity could be detected in 36 (36.7%) of DLBCL patients, and PCR analysis showed concordant results. Regarding the clinical relevance, clonal diversity was significantly associated with relapse or refractory disease. Survival analysis showed that clonal diversity is an independent prognostic factor in DLBCL (p=0.05, Cox's proportional hazard method), and stratified analyses found the most significant subgroup is the high-intermediate risk category (p=0.01, log-rank test). We conclude that clonal diversity of Ig gene rearrangements is associated with a high risk of relapse or refractory disease in DLBCL patients. It is also a factor of poor prognosis in DLBCL, especially for high-intermediate risk category.

KW - Clonal diversity

KW - Diffuse large B-cell lymphoma

KW - Immunoglobulin gene rearrangement

UR - http://www.scopus.com/inward/record.url?scp=15044339491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15044339491&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 503

EP - 508

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 3

ER -